GBPI GBM-L2B Vacuum Decay & Pressure Decay Micro-Leak Seal Tester
| Brand | GBPI |
|---|---|
| Origin | Guangdong, China |
| Manufacturer Type | Manufacturer |
| Model | GBM-L2B |
| Absolute Pressure Range | 0–300 kPa |
| Differential Pressure Range | −2–2 kPa |
| Detection Sensitivity | 1–3 µm |
| Equilibration/Test Time | 1–3600 s |
| Vacuum Purge Time | 1–3600 s |
| Set Flow Rate | 0–3 mL/min |
| Test Principle | Vacuum Decay Method / Pressure Decay Method |
| Compliance Standards | ASTM F2338-2009 (2013), YY/T 0681.18-2020, USP <1207.2>, ASTM F2095 |
Overview
The GBPI GBM-L2B Vacuum Decay & Pressure Decay Micro-Leak Seal Tester is an engineered solution for deterministic, non-destructive integrity verification of sterile and hermetically sealed primary packaging. It operates on two complementary physical principles—vacuum decay and pressure decay—enabling reliable detection of micro-leaks as small as 1 µm in rigid and semi-rigid containers. Unlike single-mode systems, the dual-sensor architecture (absolute + differential pressure transducers) eliminates ambiguity in vacuum-containing formats such as lyophilized vials, where conventional vacuum decay alone may yield false-negative results due to internal headspace vacuum masking leakage signals. The instrument applies controlled vacuum or positive pressure to a custom-fitted test chamber, then quantifies minute pressure changes over time using high-stability sensors with 0.1% full-scale accuracy. This approach satisfies the scientific rationale outlined in USP for probabilistic and deterministic leak testing, and aligns with the method validation requirements of ASTM F2338-2009 (2013) and YY/T 0681.18-2020.
Key Features
- Dual-test methodology: Simultaneous or sequential vacuum decay and pressure decay modes, resolving detection limitations in vacuum-impacted containers (e.g., lyophilized drug products).
- High-fidelity dual-sensor system: Integrated absolute pressure sensor (0–300 kPa) and differential pressure sensor (±2 kPa), both calibrated to 0.1% FS, enabling precise quantification of leak rate and equivalent leak hole diameter.
- Imported critical components: Oil-lubricated vacuum pump (3 L/s pumping speed, ≤50 dB(A) noise, ultimate vacuum ≤5 Pa) and UK-manufactured mass flow controller (resolution: 0.001 mL/min) for traceable method qualification and artificial leak simulation.
- GMP-compliant human-machine interface: 11-inch industrial-grade capacitive touchscreen with audit trail functionality, multi-level user access control (administrator, operator, reviewer), and electronic signature support per FDA 21 CFR Part 11 and EU Annex 11 requirements.
- Modular test chamber design: Fully customizable cavity geometry—including nested fixtures—for concurrent evaluation of multiple container formats (e.g., 2R–30R vials, pre-filled syringes, ampoules, HDPE bottles, IV bags) without hardware modification.
Sample Compatibility & Compliance
The GBM-L2B accommodates a broad spectrum of pharmaceutical, biotech, food, and chemical packaging formats. Validated use cases include glass and polymer-based lyophilized vials, silicone-coated pre-filled syringes, borosilicate ampoules, ophthalmic dropper bottles, flexible IV bags, and barrier-laminated pouches. All test methods are developed and verified in accordance with ICH Q5C stability guidance and ISO 11607-2 for package integrity assurance. System validation documentation supports IQ/OQ/PQ execution, and raw data files (including pressure-time curves, pass/fail flags, timestamps, and operator IDs) are stored in immutable, timestamped binary format compliant with ALCOA+ principles. The platform meets the data integrity expectations of regulatory inspections under FDA, EMA, PMDA, and NMPA frameworks.
Software & Data Management
Embedded firmware provides real-time visualization of pressure decay profiles, automatic calculation of leak rate (Pa·s⁻¹ or mL/min), and classification against user-defined acceptance criteria. Test sequences are programmable via intuitive drag-and-drop workflow editor. All actions—including parameter changes, test initiation, result overrides, and calibration events—are logged with operator ID, timestamp, and reason code. Export options include CSV (for statistical process control), PDF (for batch records), and XML (for LIMS integration). Audit trails are encrypted, non-erasable, and exportable without system administrator privileges—ensuring compliance with 21 CFR Part 11 Subpart B and EU GMP Annex 11 for computerized systems used in GxP environments.
Applications
- Final container closure integrity testing (CCIT) of sterile injectables during stability, release, and stability-indicating studies.
- Method suitability assessment for alternative leak test technologies per USP Annex 2.
- Leak rate correlation studies linking physical defect size (µm) to microbial ingress risk (per ASTM F1608).
- Process validation support for blow-fill-seal (BFS), vial capping, and syringe assembly lines.
- Root cause analysis of seal failures during packaging development or change control investigations.
FAQ
What regulatory standards does the GBM-L2B comply with?
ASTM F2338-2009 (2013), YY/T 0681.18-2020, USP , ASTM F2095, and ISO 11607-2.
Can the system detect leaks in lyophilized vials containing residual vacuum?
Yes—the dual-mode operation (vacuum decay + pressure decay) mitigates false negatives caused by internal vacuum, as required by USP Section 4.2.
Is the software 21 CFR Part 11 compliant?
Yes—full audit trail, role-based access, electronic signatures, and immutable data storage are natively implemented.
What is the smallest detectable leak size?
1 µm equivalent hole diameter for rigid containers under optimized test conditions.
Does GBPI provide IQ/OQ documentation and validation support?
Yes—comprehensive qualification templates, protocol drafting assistance, and on-site OQ execution support are available upon request.
